FI933252A0 - Nya amylinagonistpeptider och anvaendning som amylinagonister - Google Patents

Nya amylinagonistpeptider och anvaendning som amylinagonister

Info

Publication number: FI933252A0
Authority: FI; Finland
Prior art keywords: pro; ser; thr; asn; leu
Prior art date: 1991-11-19

Application number

FI933252A

Other languages

English (en)

Other versions

FI118601B (fi

FI933252L (fi

Inventor

Laura S L Gaeta

Howard Jones

Elisabeth Albrecht

Original Assignee

Amylin Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-11-19

Filing date

1993-07-16

Publication date

1993-07-16

1993-07-16 Application filed by Amylin Pharmaceuticals Inc filed Critical Amylin Pharmaceuticals Inc

1993-07-16 Publication of FI933252A0 publication Critical patent/FI933252A0/fi

1993-08-23 Publication of FI933252L publication Critical patent/FI933252L/fi

2008-01-15 Application granted granted Critical

2008-01-15 Publication of FI118601B publication Critical patent/FI118601B/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Diabetes (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
Obesity (AREA)
Hematology (AREA)
Emergency Medicine (AREA)
Immunology (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

FI933252A 1991-11-19 1993-07-16 Menetelmä terapeuttisesti käyttökelpoisen amyliiniagonistianalogin tai sen suolan valmistamiseksi FI118601B (fi)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US79426691A	1991-11-19	1991-11-19
US79426691		1991-11-19
US9209842		1992-11-19
PCT/US1992/009842 WO1993010146A1 (en)	1991-11-19	1992-11-19	Amylin agonist peptides and uses therefor

Publications (3)

Publication Number	Publication Date
FI933252A0 true FI933252A0 (fi)	1993-07-16
FI933252L FI933252L (fi)	1993-08-23
FI118601B FI118601B (fi)	2008-01-15

Family

ID=25162163

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI933252A FI118601B (fi)	1991-11-19	1993-07-16	Menetelmä terapeuttisesti käyttökelpoisen amyliiniagonistianalogin tai sen suolan valmistamiseksi

Country Status (17)

Country	Link
EP (2)	EP0567626B1 (fi)
JP (4)	JP2902115B2 (fi)
AT (1)	ATE205854T1 (fi)
AU (1)	AU714439B2 (fi)
CA (1)	CA2100745C (fi)
CZ (1)	CZ288029B6 (fi)
DE (1)	DE69232064T2 (fi)
DK (1)	DK0567626T3 (fi)
ES (1)	ES2161697T3 (fi)
FI (1)	FI118601B (fi)
GR (1)	GR3036794T3 (fi)
HK (1)	HK1041891A1 (fi)
MD (1)	MD960317A (fi)
NO (2)	NO324405B1 (fi)
RU (1)	RU2130463C1 (fi)
SK (1)	SK88793A3 (fi)
WO (1)	WO1993010146A1 (fi)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU222249B1 (hu)	1991-03-08	2003-05-28	Amylin Pharmaceuticals Inc.	Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
US5625032A (en) *	1993-07-21	1997-04-29	Amylin Pharmaceuticals, Inc.	Selective amylin antagonist peptides and uses therefor
ZA946881B (en)	1993-09-07	1995-10-30	Amylin Pharmaceuticals Inc	Methods for treating gastrointestinal motility
US5739106A (en) *	1995-06-07	1998-04-14	Rink; Timothy J.	Appetite regulating compositions
US6143718A (en) *	1995-06-07	2000-11-07	Amylin Pharmaceuticals, Inc.	Treatment of Type II diabetes mellutis with amylin agonists
US7312196B2 (en)	1997-01-08	2007-12-25	Amylin Pharmaceuticals, Inc.	Formulations for amylin agonist peptides
US6410511B2 (en)	1997-01-08	2002-06-25	Amylin Pharmaceuticals, Inc.	Formulations for amylin agonist peptides
US7101853B2 (en) *	1997-05-06	2006-09-05	Amylin Pharmaceuticals, Inc.	Method for treating or preventing gastritis using amylin or amylin agonists
US7910548B2 (en)	1997-06-06	2011-03-22	Amylin Pharmaceuticals, Inc.	Methods for treating obesity
AU760609B2 (en) *	1998-01-09	2003-05-15	Amylin Pharmaceuticals, Inc.	Formulations for amylin agonist peptides
GB0128583D0 (en)	2001-11-28	2002-01-23	Rsr Ltd	Detection of autoantibodies indicative of diabetes
US8168233B2 (en)	2002-10-18	2012-05-01	Amylin Pharmaceuticals, Inc.	Treatment of pancreatitis with amylin
CA2516726A1 (en) *	2003-03-18	2004-09-30	Applied Research Systems Ars Holding N.V.	Amylin aggregation inhibitors and use thereof
AU2005298840B2 (en) *	2004-10-26	2010-09-16	Lonza Ag	S-alkyl-sulphenyl protection groups in solid-phase synthesis
US20090156474A1 (en)	2004-11-01	2009-06-18	Amylin Pharmaceuticals, Inc.	Methods for treating obesity and obesity related diseases and disorders
US8394765B2 (en)	2004-11-01	2013-03-12	Amylin Pharmaceuticals Llc	Methods of treating obesity with two different anti-obesity agents
US7671023B2 (en)	2005-03-31	2010-03-02	Amylin Pharmaceuticals, Inc.	Amylin agonist for treating depression, anxiety disorder and schizophrenia
US8168592B2 (en)	2005-10-21	2012-05-01	Amgen Inc.	CGRP peptide antagonists and conjugates
AU2007293885A1 (en)	2006-09-07	2008-03-13	Takeda Gmbh	Combination treatment for diabetes mellitus
EP2120985B1 (en)	2007-02-05	2012-06-27	Amylin Pharmaceuticals, Inc.	FN-38 peptides for use in the treatment of psychotic and anxiety disorders
JP2009149684A (ja) *	2009-03-11	2009-07-09	Amylin Pharmaceut Inc	アミリン作動薬ペプチド用製剤
RU2537181C2 (ru)	2009-03-12	2014-12-27	Нордик Байосайенс А/С	Лечение диабета и метаболического синдрома
AR097701A1 (es) *	2013-09-19	2016-04-13	Zealand Pharma As	Análogos de amilina
JP6657101B2 (ja)	2013-11-05	2020-03-04	ベングリオンユニバーシティオブザネガフリサーチアンドディベロップメントオーソリティ	糖尿病及びそれから生じる疾患合併症の治療のための化合物
CA2947587C (en) *	2014-05-02	2022-10-18	The Research Foundation For The State University Of New York	Islet amyloid polypeptides with improved solubility
MX2017011182A (es) *	2015-03-18	2018-06-06	Zealand Pharma As	Analogos de amilina.
AR109514A1 (es)	2016-09-09	2018-12-19	Zealand Pharma As	Análogos de amilina
US11028137B2 (en)	2017-02-01	2021-06-08	The Research Foundation For The State University Of New York	Mutant islet amyloid polypeptides with improved solubility and methods for using the same
KR102130354B1 (ko) *	2019-08-14	2020-07-06	엘아이지넥스원 주식회사	코어 제거용 이형장치
IL312600A (en)	2022-05-30	2024-07-01	Zealand Pharma As	Liquid formulations of amylin analogs
AU2023346836A1 (en)	2022-09-19	2025-03-20	Zealand Pharma A/S	Combination therapy
WO2024261259A1 (en)	2023-06-21	2024-12-26	Zealand Pharma A/S	Analogues with improved properties
WO2024261076A1 (en)	2023-06-21	2024-12-26	Zealand Pharma A/S	Weight loss
WO2025003471A1 (en)	2023-06-30	2025-01-02	Zealand Pharma A/S	Combination therapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8720115D0 (en) *	1987-08-26	1987-09-30	Cooper G J S	Treatment of diabetes mellitus
WO1989006135A1 (en) *	1988-01-11	1989-07-13	Amylin Corporation	Treatment of type 2 diabetes mellitus
WO1991000737A1 (en) *	1989-07-10	1991-01-24	Amylin Corporation	Treatment of obesity and essential hypertension and related disorders
US5234906A (en) *	1991-01-10	1993-08-10	Amylin Pharmaceuticals, Inc.	Hyperglycemic compositions
WO1992015317A1 (en) *	1991-03-08	1992-09-17	Amylin Pharmaceuticals, Inc.	Synthetic preparation of amylin and amylin analogues

1992
- 1992-11-19 DK DK92924442T patent/DK0567626T3/da active
- 1992-11-19 CZ CZ19931689A patent/CZ288029B6/cs not_active IP Right Cessation
- 1992-11-19 MD MD96-0317A patent/MD960317A/ro unknown
- 1992-11-19 JP JP5509441A patent/JP2902115B2/ja not_active Expired - Lifetime
- 1992-11-19 AT AT92924442T patent/ATE205854T1/de active
- 1992-11-19 RU RU93053497A patent/RU2130463C1/ru active
- 1992-11-19 CA CA002100745A patent/CA2100745C/en not_active Expired - Lifetime
- 1992-11-19 ES ES92924442T patent/ES2161697T3/es not_active Expired - Lifetime
- 1992-11-19 EP EP92924442A patent/EP0567626B1/en not_active Expired - Lifetime
- 1992-11-19 SK SK887-93A patent/SK88793A3/sk unknown
- 1992-11-19 DE DE69232064T patent/DE69232064T2/de not_active Expired - Lifetime
- 1992-11-19 WO PCT/US1992/009842 patent/WO1993010146A1/en active IP Right Grant
- 1992-11-19 EP EP01114132A patent/EP1162207A1/en not_active Ceased
1993
- 1993-07-16 FI FI933252A patent/FI118601B/fi not_active IP Right Cessation
- 1993-07-19 NO NO19932603A patent/NO324405B1/no not_active IP Right Cessation
1997
- 1997-01-31 AU AU12456/97A patent/AU714439B2/en not_active Expired
1998
- 1998-09-30 JP JP10277573A patent/JPH11152299A/ja not_active Withdrawn
2001
- 2001-10-04 GR GR20010401656T patent/GR3036794T3/el unknown
2002
- 2002-05-02 HK HK02103291.8A patent/HK1041891A1/zh unknown
2003
- 2003-01-15 JP JP2003007228A patent/JP2003238594A/ja not_active Withdrawn
2006
- 2006-02-03 JP JP2006027334A patent/JP4018116B2/ja not_active Expired - Lifetime
2007
- 2007-06-25 NO NO20073265A patent/NO20073265L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP0567626B1 (en)	2001-09-19
AU673147B2 (en)	1996-10-31
CA2100745A1 (en)	1993-05-20
JP2003238594A (ja)	2003-08-27
DE69232064D1 (de)	2001-10-25
DK0567626T3 (da)	2001-12-17
EP0567626A1 (en)	1993-11-03
JPH11152299A (ja)	1999-06-08
MD960317A (ro)	1998-05-31
ATE205854T1 (de)	2001-10-15
RU2130463C1 (ru)	1999-05-20
FI118601B (fi)	2008-01-15
WO1993010146A1 (en)	1993-05-27
JP4018116B2 (ja)	2007-12-05
NO324405B1 (no)	2007-10-08
NO932603D0 (no)	1993-07-19
AU1245697A (en)	1997-03-27
EP1162207A1 (en)	2001-12-12
GR3036794T3 (en)	2002-01-31
SK88793A3 (en)	1994-12-07
ES2161697T3 (es)	2001-12-16
AU3075392A (en)	1993-06-15
CZ288029B6 (cs)	2001-04-11
CA2100745C (en)	2007-07-31
JP2006213716A (ja)	2006-08-17
HK1041891A1 (zh)	2002-07-26
NO932603L (no)	1993-09-17
NO20073265L (no)	1993-09-17
DE69232064T2 (de)	2002-03-28
FI933252L (fi)	1993-08-23
JP2902115B2 (ja)	1999-06-07
JPH06504794A (ja)	1994-06-02
AU714439B2 (en)	2000-01-06
CZ168993A3 (en)	1994-04-13

Publication	Publication Date	Title
FI933252A0 (fi)	1993-07-16	Nya amylinagonistpeptider och anvaendning som amylinagonister
ATE196298T1 (de)	2000-09-15	Oberflächenaktives lungenprotein und verwandte polypeptide
ES2124685T3 (es)	1999-02-16	Variantes del inhibidor de la tripsina pancreatica bovina, su produccion y uso.
DE3750197D1 (de)	1994-08-18	Antagonisten des Fibroblasten-Wachstumsfaktors.
IL89541A0 (en)	1989-09-10	Urethane-protected amino acid-n-carboxyanhydrides and their use in the synthesis of polypeptides
AU1299088A (en)	1988-08-24	Transforming growth factor-beta
DK3688A (da)	1988-07-08	Pankreatisk sekretorisk trypsininhibitor og varianter deraf fremstillet af en rekombinant vaert, fremgangsmaade, ekspressionsvektor og rekombinant vaert samt farmaceutisk anvendelse deraf
ZA896980B (en)	1990-06-27	Peptide compounds
WO1993019178A3 (en)	1993-11-25	Peptides useful for inducing tolerance
EP0348967A3 (en)	1990-09-12	Synthetic lung surfactant preparation comprising lipids and polypeptides
EP0292257A3 (en)	1990-06-06	Peptides having anf activity
DE3751398D1 (de)	1995-08-17	Substrat-Peptide.
WO1999048908A3 (fr)	1999-12-16	POLYPEPTIDE IMMUNOREACTIF DU RECEPTEUR TrkA du NGF ET UTILISATIONS
NZ231636A (en)	1993-03-26	Anticoagulant peptides analogus to hirudins' active site
DK262986D0 (da)	1986-06-04	Peptidmateriale med thymushumoral aktivitet
ATE216706T1 (de)	2002-05-15	Peptide des hiv-gag proteins, ihre herstellung und verwendung
CA2004764A1 (en)	1990-06-10	Ancrod proteins, their preparation and use
DK200200302A (da)	2002-02-27	Rekombinante polypeptider omfattende aminosyresekvensen af moden vævsfaktorinhibitor (TFI), polypeptidfragmenter deraf, ekspressionsvektorer der koder for disse, værtsceller transformeret dermed, og fremgangsmåde til fremstilling af et ........
ES2051152B1 (es)	1994-12-16	Procedimiento de sistesis de peptidos con capacidad de detectar anticuerpos anti-virus de la hepatitis c (vhc) en suero de individuos afectados.
DK411686A (da)	1987-03-03	Peptider

Legal Events

Date	Code	Title	Description
2008-01-15	FG	Patent granted	Ref document number: 118601 Country of ref document: FI
2012-12-10	PC	Transfer of assignment of patent	Owner name: AMYLIN PHARMACEUTICALS, LLC Owner name: ASTRAZENECA PHARMACEUTICALS LP
2012-12-20	MA	Patent expired

Date

Code

Title

Description

2008-01-15

Patent granted

Ref document number: 118601

Country of ref document: FI

2012-12-10

Transfer of assignment of patent

Owner name: AMYLIN PHARMACEUTICALS, LLC

Owner name: ASTRAZENECA PHARMACEUTICALS LP

2012-12-20

Patent expired